Evidence map›Paper›PMID 39851309›Full record

ArticleBioengineering (Basel, Switzerland)2025

An Effective Methodology for Diabetes Prediction in the Case of Class Imbalance.

Borislava Toleva, Ivan Atanasov, Ivan Ivanov, Vincent Hooper

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Borislava TolevaFaculty of Economics and Business Administration, Sofia University, St. Kl. Ohridski, 1113 Sofia, Bulgaria.ORCID 0000-0001-9335-6927
Ivan AtanasovFaculty of Economics and Business Administration, Sofia University, St. Kl. Ohridski, 1113 Sofia, Bulgaria.
Ivan IvanovFaculty of Economics and Business Administration, Sofia University, St. Kl. Ohridski, 1113 Sofia, Bulgaria.ORCID 0000-0002-9019-072X
Vincent HooperSP Jain Global School of Management, Academic City, Dubai P.O. Box 502345, United Arab Emirates.ORCID 0000-0001-6473-700X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes causes an increase in the level of blood sugar, which leads to damage to various parts of the human body. Diabetes data are used not only for providing a deeper understanding of the treatment mechanisms but also for predicting the probability that one might become sick. This paper proposes a novel methodology to perform classification in the case of heavy class imbalance, as observed in the PIMA diabetes dataset. The proposed methodology uses two novel steps, namely resampling and random shuffling prior to defining the classification model. The methodology is tested with two versions of cross validation that are appropriate in cases of class imbalance-k-fold cross validation and stratified k-fold cross validation. Our findings suggest that when having imbalanced data, shuffling the data randomly prior to a train/test split can help improve estimation metrics. Our methodology can outperform existing machine learning algorithms and complex deep learning models. Applying our proposed methodology is a simple and fast way to predict labels with class imbalance. It does not require additional techniques to balance classes. It does not involve preselecting important variables, which saves time and makes the model easy for analysis. This makes it an effective methodology for initial and further modeling of data with class imbalance. Moreover, our methodologies show how to increase the effectiveness of the machine learning models based on the standard approaches and make them more reliable.

Indexed as

classificationclass imbalancecross validationresampleshuffle

Identifiers

PMID39851309
PMCPMC11762348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.